Created at Source Raw Value Validated value
June 25, 2024, noon usa

* received the j\&j vaccine. * had a contraindication to receiving an mrna covid-19 vaccine * had an immediate allergic reaction to past vaccine or injection * experienced a major episode of infection requiring hospitalization or treatment with intravenous antibiotics within 2 weeks prior to the screening visit

* received the j\&j vaccine. * had a contraindication to receiving an mrna covid-19 vaccine * had an immediate allergic reaction to past vaccine or injection * experienced a major episode of infection requiring hospitalization or treatment with intravenous antibiotics within 2 weeks prior to the screening visit

June 21, 2024, 8 a.m. usa

received the j&j vaccine. had a contraindication to receiving an mrna covid-19 vaccine had an immediate allergic reaction to past vaccine or injection experienced a major episode of infection requiring hospitalization or treatment with intravenous antibiotics within 2 weeks prior to the screening visit

received the j&j vaccine. had a contraindication to receiving an mrna covid-19 vaccine had an immediate allergic reaction to past vaccine or injection experienced a major episode of infection requiring hospitalization or treatment with intravenous antibiotics within 2 weeks prior to the screening visit

May 9, 2021, 12:31 a.m. usa

- already has received pfizer, moderna or johnson & johnson vaccine - known diagnosis of covid-19 prior to screening - has a contraindication to receiving an mrna covid-19 vaccine - has an immediate allergic reaction to past vaccine or injection - any major episode of infection requiring hospitalization or treatment with intravenous antibiotics within 2 weeks prior to the screening visit

- already has received pfizer, moderna or johnson & johnson vaccine - known diagnosis of covid-19 prior to screening - has a contraindication to receiving an mrna covid-19 vaccine - has an immediate allergic reaction to past vaccine or injection - any major episode of infection requiring hospitalization or treatment with intravenous antibiotics within 2 weeks prior to the screening visit